AOAsli Ozturk

Asli Ozturk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asli Ozturk has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pelvic Floor Dysfunctions in Children With Lower Urinary Tract Dysfunction and Relationship With Urine Flow

    by Murat Dayanç, Asli Ozturk, Burak Kopru, Rabia Asik, Canan Seyhan, Hasan Cem. Irkilata

    Purpose: Pelvic floor muscle (PFM) dynamics play a significant role alongside bladder and rectal dynamics in the pathophysiology of lower urinary tract dysfunction (LUTD) in children. This study aimed to determine PFM activities (PFMA), including resting tone and contractile functions, of LUTD subtypes in children according to their voiding patterns. Materials and Methods: 160 children presenting to our clinic with symptoms of lower pelvic floor voiding (LUTD) were evaluated using noninvasive diagnostic methods, and LUTD subtypes were determined. Based on voiding patterns, 31 had intermittent, 59 had staccato, 28 had tower, 31 had bell and 11 had plateau voiding pattern. 18 healthy children served as a control group and also exhibited bell curve voiding. PFMA was measured using superficial electrodes after voiding. Children performed five cycles of 5‐s relaxation followed by 5‐s voluntary PFM contraction, resulting in a total recording period of 50 s. Mean relaxation and contraction EMG values were recorded for analysis. According to PFMA measurements, pelvic floor dysfunction (PFD) subtypes defined and frequencies determined. Results: According to the LUTD subtype, the frequency of pelvic floor overactivity (PFO) ranged from 59% to 86%, and the overall frequency of contractile dysfunctions (Nonfunctional or weak functional pelvic floor) ranged from 64% to 78%. As the voiding pattern improved, the resting tone decreased and normalized, thus the frequency of PFO reduced from 84% to 45% ( p = 0.0001). Conclusions: The measurement of PFMA enables the identification of PFD subtypes in children with LUTD. The pathophysiology of LUTD can be better understood noninvasively.

  • Multimodal Therapy for Monosymptomatic Nocturnal Enuresis: Nocturnal Bladder and Pelvic Floor Dynamics

    by Canan Seyhan, Asli Ozturk, Burak Kopru, Rabia Asik, Hasan Cem Irkilata, Murat Dayanc

    Objective: This study aimed to evaluate pelvic floor muscle activity (PFMA) in children with monosymptomatic nocturnal enuresis (MNE) and to investigate the effectiveness of multimodal treatment including standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation (PFMR) approach by assessing nocturnal bladder and pelvic floor dynamics. Methods: In this retrospective cross‐sectional study, medical records of children with primary MNE were reviewed. All participants received a multimodal treatment consisting of (i) standard urotherapy based on International Children's Continence Society recommendations, (ii) enuresis alarm therapy with objective nocturnal urine volume monitoring, and (iii) individualized PFMR. PFMR was designed according to baseline PFMA assessed objectively using surface electromyography and included relaxation‐oriented interventions for pelvic floor overactivity, coordination training, and strength and endurance exercises integrated with core muscles. Nocturnal bladder dynamics, PFMA parameters, and treatment outcomes were retrospectively analyzed. Treatment response was classified as complete, partial, or no response. Results: A total of 65 children were included. At baseline, 67.7% of children had pelvic floor overactivity, and 64.7% had nonfunctional or weak functional pelvic floor. Both pelvic floor dysfunctions coexisted in 25 children (38%). During multimodal therapy, objective nocturnal measures demonstrated a significant reduction in alarm activations and diaper urine volume, alongside increased voided volumes (all p < 0.001). Resting tone, contraction and functional contraction amplitude were significantly improved after treatment (all p < 0.001). Complete response was achieved in 75.4% of children at 12 weeks and increased to 93.8% at 16 weeks. Conclusion: Multimodal treatment combining standard urotherapy, alarm therapy with individualized PFMR based on objective PFMA assessment appears highly effective in children with MNE and may optimize both pelvic floor function and nocturnal bladder dynamics.